Mannatech, Incorporated announced James Clavijo has been named Chief Financial Officer. Clavijo brings more than 25 years of experience in executive leadership, finance and accounting and has specific expertise within the medical technology, biotech and pharmaceutical categories.

Landen Fredrick, who has served as the interim CFO since January 2024, will now focus on leading and overseeing the executive team and driving operational excellence.

“The company engaged in an extensive search for a qualified financial expert to oversee the company’s global finance organization as we strive to create shareholder value,” Fredrick said. “We are pleased to welcome James Clavijo to Mannatech.”